Mutual of America Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$62.9K Sell
11,841
-1,416
-11% -$7.52K ﹤0.01% 1368
2025
Q1
$118K Sell
13,257
-533
-4% -$4.73K ﹤0.01% 1389
2024
Q4
$189K Buy
13,790
+130
+1% +$1.78K ﹤0.01% 1390
2024
Q3
$374K Sell
13,660
-1,217
-8% -$33.3K ﹤0.01% 1228
2024
Q2
$364K Sell
14,877
-376
-2% -$9.2K ﹤0.01% 1223
2024
Q1
$325K Sell
15,253
-266
-2% -$5.67K ﹤0.01% 1283
2023
Q4
$297K Buy
15,519
+1,167
+8% +$22.3K ﹤0.01% 1301
2023
Q3
$230K Sell
14,352
-1,577
-10% -$25.3K ﹤0.01% 1339
2023
Q2
$369K Sell
15,929
-758
-5% -$17.6K ﹤0.01% 1222
2023
Q1
$388K Sell
16,687
-296
-2% -$6.88K ﹤0.01% 1196
2022
Q4
$246K Buy
16,983
+940
+6% +$13.6K ﹤0.01% 1333
2022
Q3
$306K Buy
16,043
+2,549
+19% +$48.6K ﹤0.01% 1225
2022
Q2
$245K Buy
13,494
+1,987
+17% +$36.1K ﹤0.01% 1267
2022
Q1
$290K Buy
11,507
+597
+5% +$15K ﹤0.01% 1227
2021
Q4
$301K Buy
10,910
+501
+5% +$13.8K ﹤0.01% 1229
2021
Q3
$336K Sell
10,409
-545
-5% -$17.6K ﹤0.01% 1199
2021
Q2
$335K Buy
10,954
+910
+9% +$27.8K ﹤0.01% 1245
2021
Q1
$306K Buy
10,044
+647
+7% +$19.7K ﹤0.01% 1253
2020
Q4
$186K Buy
9,397
+392
+4% +$7.76K ﹤0.01% 1306
2020
Q3
$117K Buy
9,005
+5,396
+150% +$70.1K ﹤0.01% 1354
2020
Q2
$41K Buy
3,609
+334
+10% +$3.79K ﹤0.01% 1394
2020
Q1
$47K Buy
3,275
+636
+24% +$9.13K ﹤0.01% 1302
2019
Q4
$72K Sell
2,639
-139
-5% -$3.79K ﹤0.01% 1257
2019
Q3
$80K Buy
2,778
+152
+6% +$4.38K ﹤0.01% 1237
2019
Q2
$73K Buy
2,626
+529
+25% +$14.7K ﹤0.01% 1249
2019
Q1
$70K Buy
2,097
+273
+15% +$9.11K ﹤0.01% 1213
2018
Q4
$53K Buy
1,824
+475
+35% +$13.8K ﹤0.01% 1226
2018
Q3
$62K Buy
1,349
+1,092
+425% +$50.2K ﹤0.01% 1211
2018
Q2
$10K Buy
+257
New +$10K ﹤0.01% 1243